Cencora (NYSE:COR) Board Announces Stock Buyback Plan

Cencora (NYSE:COR) announced that its Board of Directors has initiated a share repurchase program on Thursday, May 21st, RTT News reports. The company plans to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 3.9% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

Analysts Set New Price Targets

Several research firms have recently weighed in on COR. UBS Group lifted their price objective on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cencora in a research note on Monday, May 4th. Wells Fargo & Company reduced their price objective on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research note on Monday, May 11th. Morgan Stanley set a $342.00 price objective on Cencora in a research note on Friday, May 8th. Finally, Leerink Partners reiterated an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Cencora has a consensus rating of “Moderate Buy” and a consensus price target of $380.25.

Cencora Stock Up 0.2%

COR stock traded up $0.62 during midday trading on Thursday, hitting $265.37. 1,300,707 shares of the company’s stock were exchanged, compared to its average volume of 2,297,795. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. Cencora has a 12-month low of $244.82 and a 12-month high of $377.54. The firm has a 50 day moving average price of $307.20 and a 200-day moving average price of $337.20. The stock has a market capitalization of $51.63 billion, a price-to-earnings ratio of 20.35, a price-to-earnings-growth ratio of 1.22 and a beta of 0.64.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The business had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter in the prior year, the firm earned $4.42 earnings per share. Cencora’s revenue for the quarter was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, analysts anticipate that Cencora will post 17.76 EPS for the current year.

Cencora Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be given a $0.60 dividend. The ex-dividend date is Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. Cencora’s dividend payout ratio (DPR) is presently 18.40%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.